Giovanni Magnaghi is the new Chief Executive Officer of Zambon SpA
02 May 2024 //
PRESS RELEASE
Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203
27 Feb 2024 //
PRESS RELEASE
Zambon to Attend the CHEST Annual Meeting 2022
14 Oct 2022 //
PR NEWSWIRE
Luye Grants Zambon Commercialization Rights to Alzheimer`s Disease Treatment
11 Nov 2021 //
FIRSTWORDPHARMA
Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors
18 Feb 2018 //
BUSINESSWIRE
Zambon’s Xadago (Safinamide) Approved In Europe For Mid-Late Stage PD Patients
26 Feb 2015 //
BIOSPACE
Safinamide New Drug Application (NDA) Re-submitted to the US Food and Drug Administration (FDA)
29 Dec 2014 //
NEWRON PHARMACEUTICALS